Hepatitis C Virus Infection Completed Phase 2 / 3 Trials for Ribavirin (DB00811)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0033268 (Hepatitis C Virus Infection) | Completed | 2 / 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01939197 | A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection | Treatment |